William Blair Comments on Lonza Group AG’s FY2025 Earnings (OTCMKTS:LZAGY)

Lonza Group AG (OTCMKTS:LZAGY) – Equities research analysts at William Blair lowered their FY2025 earnings estimates for shares of Lonza Group in a research report issued to clients and investors on Monday, October 7th. William Blair analyst M. Smock now forecasts that the company will earn $1.78 per share for the year, down from their previous forecast of $1.81. The consensus estimate for Lonza Group’s current full-year earnings is $1.57 per share.

Separately, Berenberg Bank upgraded Lonza Group to a “strong-buy” rating in a research note on Sunday, June 23rd.

Lonza Group Stock Up 0.3 %

Shares of LZAGY opened at $61.53 on Wednesday. The company’s 50-day moving average price is $64.14 and its 200 day moving average price is $59.49. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.20 and a current ratio of 1.77. Lonza Group has a 12-month low of $34.19 and a 12-month high of $67.00.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.